{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:02:46Z","timestamp":1787169766613,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in infertile women characterized by both reproductive and metabolic dysfunctions of different degrees. Furthermore, it has been associated with increased cardiovascular disease (CVD) risk and related long-term health sequela. The aim of this study is to evaluate serum homocysteine (Hcy) and C-reactive protein (CRP) levels in women with PCOS and to evaluate their relationship with clinical and laboratory parameters in women with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The prospective single-center study included 45 women with PCOS (study group) and 41 control subjects. Demographic variables and Hcy, CRP, fasting blood glucose, insulin, follicle-stimulating hormone, luteinizing hormone, estradiol, total and free testosterone, dehydroepiandrosterone sulfate, thyroid-stimulating hormone levels, and lipid profiles of the subjects were recorded. homeostatic model assessment for insulin resistance (HOMA-IR) indexes were calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Fasting plasma glucose, insulin, HOMA-IR, free and total testosterone levels, and clinical hirsutism were significantly higher in the study group. There was no statistically significant difference in lipid profile between groups. Hcy and CRP levels were higher in the study group, which was not statistically significantly different (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Some of the parameters that are correlated with CVD risk were found to be higher in women with PCOS, although the difference for Hcy and CRP did not reach statistical significance. However, the current study reveals that the CVD risk associated with PCOS deserves more comprehensive prospective studies with long-term outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/gmit.gmit_30_20","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T02:44:11Z","timestamp":1636080251000},"page":"210-214","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Homocysteine and C-reactive Protein Levels in Women with Polycystic Ovary Syndrome"],"prefix":"10.4103","volume":"10","author":[{"given":"Murat","family":"G\u00f6z\u00fck\u00fc\u00e7\u00fck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asl\u0131 Yarc\u0131","family":"G\u00fcrsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Desteg\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"Ta\u015fk\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"\u015eat\u0131ro\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20240830","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"R2-3-20240830","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2147\/IJWH.S70314","article-title":"Complications and challenges associated with polycystic ovary syndrome: Current perspectives","volume":"7","author":"Palomba","year":"2015","journal-title":"Int J Womens Health"},{"key":"R3-3-20240830","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R4-3-20240830","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0002-9378(96)70665-8","article-title":"Carotid atherosclerosis in women with polycystic ovary syndrome: \u0130nitial results from a case-control study","volume":"174","author":"Guzick","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"R5-3-20240830","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R6-3-20240830","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3109\/09513590.2011.589927","article-title":"Homocysteine metabolism in polycystic ovary syndrome","volume":"28","author":"Grodnitskaya","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"R7-3-20240830","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/humupd\/dml063","article-title":"Impact of folate and homocysteine metabolism on human reproductive health","volume":"13","author":"Forges","year":"2007","journal-title":"Hum Reprod Update"},{"key":"R9-3-20240830","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","author":"Toulis","year":"2011","journal-title":"Hum Reprod Update"},{"key":"R10-3-20240830","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","article-title":"Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence","volume":"131","author":"Eikelboom","year":"1999","journal-title":"Ann Intern Med"},{"key":"R11-3-20240830","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4065\/83.11.1203","article-title":"Homocysteine level and coronary heart disease incidence: A systematic review and meta-analysis","volume":"83","author":"Humphrey","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"R12-3-20240830","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1055\/s-0037-1614598","article-title":"Vegetarians and cardiovascular risk factors: Hemostasis, inflammatory markers and plasma homocysteine","volume":"81","author":"Mezzano","year":"1999","journal-title":"Thromb Haemost"},{"key":"R13-3-20240830","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1521-6934(03)00009-9","article-title":"Homocysteine and pregnancy","volume":"17","author":"Hague","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R14-3-20240830","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2796.2002.01019.x","article-title":"Inflammatory bio-markers and cardiovascular risk prediction","volume":"252","author":"Blake","year":"2002","journal-title":"J Intern Med"},{"key":"R15-3-20240830","first-page":"143","article-title":"CRP at early follicular phase of menstrual cycle can cause misinterpretation for cardiovascular risk assessment","volume":"7","author":"Gursoy","year":"2015","journal-title":"Interv Med Appl Sci"},{"key":"R16-3-20240830","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"R17-3-20240830","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.106.649939","article-title":"PEACE Investigators. Prognostic significance of the Centers for Disease Control\/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease","volume":"115","author":"Sabatine","year":"2007","journal-title":"Circulation"},{"key":"R18-3-20240830","first-page":"320","article-title":"Clomiphene citrate treatment cycle outcomes of polycystic ovary syndrome patients based on basal high sensitive C-reactive protein levels: A cross-sectional study","volume":"10","author":"Kahyaoglu","year":"2017","journal-title":"Int J Fertil Steril"},{"key":"R20-3-20240830","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: \u0130nsulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"R21-3-20240830","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1464-5491.2002.00719.x","article-title":"Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death","volume":"19","author":"Hedblad","year":"2002","journal-title":"Diabet Med"},{"key":"R22-3-20240830","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejogrb.2010.10.001","article-title":"Modified Ferriman-Gallwey hirsutism score and androgen levels in Turkish women","volume":"154","author":"Coskun","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R23-3-20240830","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/humupd\/dms059","article-title":"Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): A systematic review and meta-analysis","volume":"19","author":"Murri","year":"2013","journal-title":"Hum Reprod Update"},{"key":"R24-3-20240830","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1365-2362.1995.tb01688.x","article-title":"Critical points for determining moderate hyperhomocyst(e)inaemia","volume":"25","author":"Kang","year":"1995","journal-title":"Eur J Clin Invest"},{"key":"R25-3-20240830","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1055\/s-0037-1613864","article-title":"The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events","volume":"83","author":"D'Angelo","year":"2000","journal-title":"Thromb Haemost"},{"key":"R26-3-20240830","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1055\/s-0037-1613862","article-title":"Intermediate and severe hyperhomocysteinemia with thrombosis: A study of genetic determinants","volume":"83","author":"Gaustadnes","year":"2000","journal-title":"Thromb Haemost"},{"key":"R27-3-20240830","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7326\/0003-4819-138-11-200306030-00010","article-title":"Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States","volume":"138","author":"Bazzano","year":"2003","journal-title":"Ann Intern Med"},{"key":"R28-3-20240830","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2265.2004.02019.x","article-title":"Plasma homocysteine in polycystic ovary syndrome: Does it correlate with insulin resistance and ethnicity?","volume":"60","author":"Wijeyaratne","year":"2004","journal-title":"Clin Endocrinol (Oxf"},{"key":"R29-3-20240830","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejogrb.2006.10.015","article-title":"Plasma homocysteine and polycystic ovary syndrome: The missed link","volume":"131","author":"Badawy","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R30-3-20240830","first-page":"31","article-title":"Status of homocysteine in polycystic ovary syndrome (PCOS)","volume":"8","author":"Maleedhu","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"R31-3-20240830","first-page":"138","article-title":"Serum homocysteine and metabolic syndrome in middle-aged and elderly men","volume":"22","author":"Zhao","year":"2016","journal-title":"Zhonghua Nan Ke Xue"},{"key":"R32-3-20240830","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.02764.x","article-title":"Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: \u0130mplications for the management of polycystic ovary syndrome","volume":"66","author":"Barber","year":"2007","journal-title":"Clin Endocrinol (Oxf"},{"key":"R33-3-20240830","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/humupd\/dml054","article-title":"The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility","volume":"13","author":"Ebisch","year":"2007","journal-title":"Hum Reprod Update"},{"key":"R34-3-20240830","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/humrep\/16.6.1086","article-title":"The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome","volume":"16","author":"Fedorcs\u00e1k","year":"2001","journal-title":"Hum Reprod"},{"key":"R35-3-20240830","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/aje\/kwr343","article-title":"Endogenous reproductive hormones and C-reactive protein across the menstrual cycle: The BioCycle Study","volume":"175","author":"Gaskins","year":"2012","journal-title":"Am J Epidemiol"},{"key":"R36-3-20240830","doi-asserted-by":"crossref","first-page":"11J","DOI":"10.1016\/S0002-9149(99)00351-3","article-title":"Epidemiology of insulin resistance and its relation to coronary artery disease","volume":"84","author":"Haffner","year":"1999","journal-title":"Am J Cardiol"},{"key":"R37-3-20240830","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"R38-3-20240830","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"R39-3-20240830","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4236\/ojog.2018.81005","article-title":"The effects of plasma homocysteine in PCOS women: A review","volume":"8","author":"Maharjan","year":"2018","journal-title":"Open J Obstet Gynecol"},{"key":"R40-3-20240830","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1507\/endocrj.51.601","article-title":"Plasma homocysteine levels in polycystic ovary syndrome and congenital adrenal hyperplasia","volume":"51","author":"Bayraktar","year":"2004","journal-title":"Endocr J"},{"key":"R41-3-20240830","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-61-5-946","article-title":"Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome","volume":"61","author":"Wild","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"R42-3-20240830","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2265.1996.674495.x","article-title":"Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries","volume":"44","author":"Robinson","year":"1996","journal-title":"Clin Endocrinol (Oxf"}],"container-title":["Gynecology and Minimally Invasive Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/GMIT.GMIT_30_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:12:01Z","timestamp":1787166721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/GMIT.GMIT_30_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/gmit.gmit_30_20","relation":{},"ISSN":["2213-3070"],"issn-type":[{"value":"2213-3070","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}